FIG vs GILD · rev $274.2M vs P/E 18, rev $29.44B
Figma, Inc. (FIG) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Figma, Inc. (FIG) is a software - application company listed on NYSE.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FIG revenue for 2025-09-30 was $274.2M. Net income was -$1.10B. Revenue was up 9.8% from 2025-06-30 to 2025-09-30. FIG currently screens at market cap $9.56B.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FIG currently screens at market cap $9.56B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FIG and GILD stock pages for the full models.
Not investment advice.